CPIX
Cumberland Pharmaceuticals Inc
7.90$
-3.2%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +66.7% | +57.5% | +25.0% | +24.1% | +5.4% | +11.5% | -4.5% | -34.4% | +15.2% | -9.2% | -1.5% | +24.6% | -1.0% | -15.6% | +8.9% | -3.9% | +16.7% | -5.9% | -4.3% | +17.6% | |
| – | +349.9% | +11.3% | +14.1% | +35.8% | -13.3% | +49.5% | -5.9% | +7.8% | -7.1% | -1.7% | +19.9% | +23.7% | +0.1% | +0.6% | +16.6% | +1.8% | +3.5% | -33.5% | +8.6% | +1.2% | |
| – | +51.8% | +64.7% | +26.1% | +23.0% | +7.3% | +8.3% | -4.3% | -39.3% | +19.8% | -10.4% | -5.2% | +24.8% | -1.2% | -19.2% | +6.8% | -5.6% | +21.0% | +1.8% | -6.6% | +21.0% | |
| – | +92.9% | +65.4% | +19.9% | +12.7% | -13.3% | +16.2% | +1.3% | +10.2% | -39.6% | +13.5% | -17.1% | +22.3% | +87.6% | -6.2% | -15.9% | -1.5% | +17.7% | -12.8% | -17.4% | +15.6% | |
| – | +15.9% | +38.0% | +24.2% | +48.7% | +4.5% | +15.1% | -1.1% | +4.3% | -11.5% | -9.5% | +12.5% | +17.2% | +3.7% | -4.1% | +2.2% | -4.1% | +4.1% | +4.6% | +4.5% | +7.4% | |
| – | +40.2% | +41.5% | +32.6% | +35.9% | +6.4% | +0.4% | -2.6% | -13.1% | -6.9% | -3.0% | +3.9% | +32.8% | +7.6% | -11.0% | -3.0% | -0.9% | +10.7% | +11.5% | -12.4% | +7.8% | |
| – | +196.5% | +202.4% | +8.3% | -20.7% | +12.6% | +51.5% | -10.5% | -143.1% | – | -131.2% | – | – | – | – | – | – | – | – | – | – | |
| – | +1,042.0% | -11.4% | -66.7% | +262.4% | +84.2% | -75.2% | -79.6% | +43.7% | -35.1% | +10.1% | +44.1% | -12.7% | +110.8% | +25.7% | +7.1% | -62.8% | +497.8% | +14.0% | -9.3% | -18.1% | |
| – | +121.7% | +278.7% | +13.0% | -30.5% | +3.8% | +83.9% | -6.8% | -140.6% | – | -66.7% | -207.1% | – | – | – | – | – | – | – | – | – | |
| – | – | – | +4.9% | -20.4% | +40.9% | +43.1% | -20.5% | -146.9% | – | -58.3% | -157.5% | – | -99.6% | -576.8% | – | -37.6% | +97.3% | -33.5% | -149.5% | – | |
| – | +125.4% | -8.2% | +17.8% | -35.1% | -20.5% | +130.3% | +3.3% | -136.0% | – | -69.8% | -229.2% | – | – | – | – | – | – | – | – | – | |
| – | +242.0% | +160.8% | +5.6% | -19.7% | +15.1% | +43.2% | -8.9% | -122.6% | – | -37.8% | -67.2% | -197.1% | – | – | – | – | – | +646.6% | -92.7% | +1,521.2% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.